Search all trials

Find therapies in clinical trials near you – page 5

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Hidradenitis

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Spain

Participants:18–64 years
Substances:Golimumab

Contact Research Centre

Psoriasis

Not recruiting

Registered drug

Study on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Brodalumab

Contact Research Centre

Dermatitis atopic

Not recruiting

InvestigationalNo placebo

Study on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis

InvestigationalNo placebo

Spain

Participants:18–64 years
Substances:Upadacitinib

Contact Research Centre

Colorectal cancer metastatic+1

Not recruiting

Registered drugNo placebo

Study on Preventing Blood Clots with Tinzaparin in Patients with Metastatic Colorectal Cancer Starting First-Line Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Tinzaparin Sodium

Contact Research Centre

Pulmonary tuberculosis

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of High-Dose Rifampicin, Moxifloxacin, and Linezolid for Patients with Pulmonary Tuberculosis

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Cyanocobalamin

Contact Research Centre

End stage renal disease+1

Not recruiting

Registered drugNo placebo

Study Comparing Rifampicin, Isoniazid, and Rifapentine Regimens for Treating Latent Tuberculosis in Patients with End-Stage Kidney Disease

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Isoniazid

Contact Research Centre

Anal fistula

Not recruiting

Registered drugNo placebo

Study on the Long-Term Safety of Darvadstrocel for Adults with Crohn's Disease and Complex Perianal Fistulas

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded

Contact Research Centre

Chronic hepatitis B+1

Not recruiting

Investigational

Study of Bepirovirsen for Patients with Chronic Hepatitis B on Nucleos(t)ide Analogue Treatment

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Bepirovirsen

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Obefazimod

Contact Research Centre

Portal hypertension

Not recruiting

Registered drugNo placebo

Study on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Bi 685509

Contact Research Centre

Find therapies in clinical trials near you – page 5

65 trials match your criteria

Hidradenitis

Study on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Colitis ulcerative

Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Psoriasis

Study on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More

Dermatitis atopic

Study on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis

Colorectal cancer metastatic+1

Study on Preventing Blood Clots with Tinzaparin in Patients with Metastatic Colorectal Cancer Starting First-Line Treatment

Pulmonary tuberculosis

Study on the Effectiveness and Safety of High-Dose Rifampicin, Moxifloxacin, and Linezolid for Patients with Pulmonary Tuberculosis

End stage renal disease+1

Study Comparing Rifampicin, Isoniazid, and Rifapentine Regimens for Treating Latent Tuberculosis in Patients with End-Stage Kidney Disease

Anal fistula

Study on the Long-Term Safety of Darvadstrocel for Adults with Crohn's Disease and Complex Perianal Fistulas

Chronic hepatitis B+1

Study of Bepirovirsen for Patients with Chronic Hepatitis B on Nucleos(t)ide Analogue Treatment

Hidradenitis

Study on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Colitis ulcerative

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Portal hypertension

Study on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.